US Patent Issued to Board of Regents, The University of Texas System on April 29 for "Inhibitors of receptor interacting protein kinase I for the treatment of disease" (Texas Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,406, issued on April 29, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Inhibitors of receptor interacting protein kinase I for the treatment of disease" was invented by Richard T. Lewis (Missouri City, Texas), Matthew Michael Hamilton (Missouri City, Texas), William J. Ray (Houston), Fernando Alvarez (Austin, Texas), Dana E. Pfaffinger (Houston), Naphtali Reyna (Arlington, Texas), Jason Cross (Pearland, Texas) and Suyambu Kesava Vijayan Ramaswamy (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1...